| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.66e-08 | 15 | 115 | 5 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 4.66e-05 | 112 | 115 | 6 | GO:0090079 | |
| GeneOntologyBiologicalProcess | female meiosis II | 3.36e-11 | 6 | 118 | 5 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 3.36e-11 | 6 | 118 | 5 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 3.36e-11 | 6 | 118 | 5 | GO:0061983 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.02e-08 | 31 | 118 | 6 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 3.36e-07 | 26 | 118 | 5 | GO:0045836 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 5.07e-07 | 52 | 118 | 6 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 5.99e-07 | 29 | 118 | 5 | GO:0045948 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.12e-06 | 37 | 118 | 5 | GO:0051446 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 5.25e-06 | 77 | 118 | 6 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 5.73e-06 | 45 | 118 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 7.12e-06 | 47 | 118 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.07e-05 | 87 | 118 | 6 | GO:1902373 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.12e-05 | 308 | 118 | 10 | GO:0043487 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.14e-05 | 88 | 118 | 6 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.38e-05 | 91 | 118 | 6 | GO:0006446 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.51e-05 | 101 | 118 | 6 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.23e-05 | 115 | 118 | 6 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 7.06e-05 | 75 | 118 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 1.08e-04 | 82 | 118 | 5 | GO:0051445 | |
| GeneOntologyBiologicalProcess | translational initiation | 1.12e-04 | 132 | 118 | 6 | GO:0006413 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | SPRY2 ABCA1 DENND4A RIPOR2 RALGAPB ARHGEF11 PLEKHG4B DLC1 AUTS2 | 1.28e-04 | 333 | 118 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.91e-04 | 432 | 118 | 10 | GO:0006401 | |
| GeneOntologyBiologicalProcess | oocyte development | 2.62e-04 | 99 | 118 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.79e-04 | 292 | 118 | 8 | GO:0043488 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 3.15e-04 | 103 | 118 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 3.37e-04 | 464 | 118 | 10 | GO:0141188 | |
| GeneOntologyBiologicalProcess | embryonic organ development | SP1 SPRY2 RIPOR2 HIPK1 DVL1 BIRC6 CCDC39 BPTF USH1G KDR WDR48 | 3.79e-04 | 561 | 118 | 11 | GO:0048568 |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 4.08e-04 | 309 | 118 | 8 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 4.70e-04 | 172 | 118 | 6 | GO:0051783 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 5.89e-04 | 118 | 118 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 6.09e-04 | 251 | 118 | 7 | GO:2000241 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.59e-05 | 109 | 118 | 6 | GO:0005796 | |
| Domain | SEA | 1.44e-06 | 14 | 118 | 4 | SM00200 | |
| Domain | DEP | 1.01e-05 | 22 | 118 | 4 | PF00610 | |
| Domain | DEP | 1.01e-05 | 22 | 118 | 4 | PS50186 | |
| Domain | SEA | 1.01e-05 | 22 | 118 | 4 | PF01390 | |
| Domain | DEP | 1.01e-05 | 22 | 118 | 4 | SM00049 | |
| Domain | DEP_dom | 1.22e-05 | 23 | 118 | 4 | IPR000591 | |
| Domain | SEA | 1.22e-05 | 23 | 118 | 4 | PS50024 | |
| Domain | SEA_dom | 1.22e-05 | 23 | 118 | 4 | IPR000082 | |
| Domain | Cell_morpho_N | 3.96e-05 | 2 | 118 | 2 | IPR025614 | |
| Domain | DVL-1 | 3.96e-05 | 2 | 118 | 2 | IPR008340 | |
| Domain | MOR2-PAG1_mid | 3.96e-05 | 2 | 118 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 3.96e-05 | 2 | 118 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 3.96e-05 | 2 | 118 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 3.96e-05 | 2 | 118 | 2 | PF14222 | |
| Domain | Cell_Morphogen_C | 3.96e-05 | 2 | 118 | 2 | IPR025481 | |
| Domain | - | 1.06e-04 | 15 | 118 | 3 | 3.30.70.960 | |
| Domain | WHTH_DNA-bd_dom | 1.52e-04 | 242 | 118 | 8 | IPR011991 | |
| Domain | Dishevelled_fam | 2.36e-04 | 4 | 118 | 2 | IPR008339 | |
| Domain | Dishevelled | 2.36e-04 | 4 | 118 | 2 | PF02377 | |
| Domain | Dishevelled_protein_dom | 2.36e-04 | 4 | 118 | 2 | IPR003351 | |
| Domain | PH | KIF1A PLEKHA4 ARHGEF11 PLEKHM1 PLEKHG4B ITSN2 OSBPL6 PLEKHA1 | 3.88e-04 | 278 | 118 | 8 | SM00233 |
| Domain | PH_DOMAIN | KIF1A PLEKHA4 ARHGEF11 PLEKHM1 PLEKHG4B ITSN2 OSBPL6 PLEKHA1 | 3.97e-04 | 279 | 118 | 8 | PS50003 |
| Domain | PH_domain | KIF1A PLEKHA4 ARHGEF11 PLEKHM1 PLEKHG4B ITSN2 OSBPL6 PLEKHA1 | 4.07e-04 | 280 | 118 | 8 | IPR001849 |
| Domain | RRM | 4.60e-04 | 217 | 118 | 7 | SM00360 | |
| Domain | - | 4.73e-04 | 218 | 118 | 7 | 1.10.10.10 | |
| Domain | WxxW_domain | 5.84e-04 | 6 | 118 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.84e-04 | 6 | 118 | 2 | PF13330 | |
| Domain | RRM_dom | 6.01e-04 | 227 | 118 | 7 | IPR000504 | |
| Domain | RRM | 6.50e-04 | 230 | 118 | 7 | PS50102 | |
| Domain | VWC | 7.18e-04 | 28 | 118 | 3 | PF00093 | |
| Domain | DIX | 8.14e-04 | 7 | 118 | 2 | PF00778 | |
| Domain | DIX | 8.14e-04 | 7 | 118 | 2 | IPR001158 | |
| Domain | DIX | 8.14e-04 | 7 | 118 | 2 | PS50841 | |
| Domain | DAX | 8.14e-04 | 7 | 118 | 2 | SM00021 | |
| Domain | Hirudin/antistatin | 8.14e-04 | 7 | 118 | 2 | IPR011061 | |
| Domain | - | KIF1A PLEKHA4 ARHGEF11 PLEKHM1 PLEKHG4B GTF2H1 ITSN2 OSBPL6 PLEKHA1 | 8.47e-04 | 391 | 118 | 9 | 2.30.29.30 |
| Domain | - | 9.19e-04 | 244 | 118 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.27e-03 | 258 | 118 | 7 | IPR012677 | |
| Domain | VWFC_1 | 1.51e-03 | 36 | 118 | 3 | PS01208 | |
| Domain | PH_dom-like | KIF1A PLEKHA4 ARHGEF11 PLEKHM1 PLEKHG4B GTF2H1 ITSN2 OSBPL6 PLEKHA1 | 1.54e-03 | 426 | 118 | 9 | IPR011993 |
| Domain | VWC | 1.77e-03 | 38 | 118 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.77e-03 | 38 | 118 | 3 | PS50184 | |
| Domain | PDZ | 2.02e-03 | 141 | 118 | 5 | PF00595 | |
| Domain | RRM_1 | 2.08e-03 | 208 | 118 | 6 | PF00076 | |
| Domain | VWF_dom | 2.36e-03 | 42 | 118 | 3 | IPR001007 | |
| Domain | PDZ | 2.49e-03 | 148 | 118 | 5 | SM00228 | |
| Domain | TIL | 2.51e-03 | 12 | 118 | 2 | PF01826 | |
| Domain | C8 | 2.51e-03 | 12 | 118 | 2 | PF08742 | |
| Domain | PDZ | 2.72e-03 | 151 | 118 | 5 | PS50106 | |
| Domain | PDZ | 2.80e-03 | 152 | 118 | 5 | IPR001478 | |
| Domain | Unchr_dom_Cys-rich | 2.95e-03 | 13 | 118 | 2 | IPR014853 | |
| Domain | C8 | 2.95e-03 | 13 | 118 | 2 | SM00832 | |
| Domain | TIL_dom | 3.43e-03 | 14 | 118 | 2 | IPR002919 | |
| Domain | Glyco_hormone_CN | 3.94e-03 | 15 | 118 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.94e-03 | 15 | 118 | 2 | PF00007 | |
| Domain | VWD | 4.48e-03 | 16 | 118 | 2 | SM00216 | |
| Domain | VWF_type-D | 4.48e-03 | 16 | 118 | 2 | IPR001846 | |
| Domain | VWFD | 4.48e-03 | 16 | 118 | 2 | PS51233 | |
| Domain | VWD | 4.48e-03 | 16 | 118 | 2 | PF00094 | |
| Domain | CTCK_1 | 5.67e-03 | 18 | 118 | 2 | PS01185 | |
| Domain | VWC_out | 6.31e-03 | 19 | 118 | 2 | SM00215 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.11e-08 | 16 | 86 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.39e-08 | 17 | 86 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.42e-07 | 21 | 86 | 5 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.32e-07 | 23 | 86 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.47e-07 | 26 | 86 | 5 | M27483 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.11e-06 | 35 | 86 | 5 | MM15948 | |
| Pathway | WP_MALE_INFERTILITY | 2.87e-05 | 145 | 86 | 7 | M39856 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.15e-05 | 60 | 86 | 5 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.70e-05 | 62 | 86 | 5 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.79e-05 | 68 | 86 | 5 | M27303 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 8.91e-05 | 301 | 86 | 9 | MM15983 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.11e-04 | 140 | 86 | 6 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.34e-04 | 109 | 86 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.80e-04 | 111 | 86 | 5 | M27416 | |
| Pubmed | 1.49e-15 | 6 | 120 | 6 | 17219433 | ||
| Pubmed | 1.24e-13 | 9 | 120 | 6 | 20159962 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 23579190 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.50e-13 | 5 | 120 | 5 | 8679003 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 22293198 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.50e-13 | 5 | 120 | 5 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.50e-13 | 5 | 120 | 5 | 8968756 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.50e-13 | 5 | 120 | 5 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.50e-13 | 5 | 120 | 5 | 26411291 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.50e-13 | 5 | 120 | 5 | 14648873 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 8896558 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.50e-13 | 5 | 120 | 5 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.50e-13 | 5 | 120 | 5 | 9288969 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.50e-13 | 5 | 120 | 5 | 10903443 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.50e-13 | 5 | 120 | 5 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.50e-13 | 5 | 120 | 5 | 8845845 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.50e-13 | 5 | 120 | 5 | 19783541 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 17761180 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.50e-13 | 5 | 120 | 5 | 12200456 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 11514340 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.50e-13 | 5 | 120 | 5 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.50e-13 | 5 | 120 | 5 | 23223451 | |
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 11804965 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 21270429 | ||
| Pubmed | 4.50e-13 | 5 | 120 | 5 | 8661148 | ||
| Pubmed | 1.35e-12 | 12 | 120 | 6 | 16887828 | ||
| Pubmed | 2.50e-12 | 13 | 120 | 6 | 12511597 | ||
| Pubmed | 2.50e-12 | 13 | 120 | 6 | 35671285 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.69e-12 | 6 | 120 | 5 | 18452650 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.69e-12 | 6 | 120 | 5 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.69e-12 | 6 | 120 | 5 | 31355046 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 20157580 | ||
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.69e-12 | 6 | 120 | 5 | 26077710 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 17526644 | ||
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.69e-12 | 6 | 120 | 5 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.69e-12 | 6 | 120 | 5 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.69e-12 | 6 | 120 | 5 | 23417416 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 32170089 | ||
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 16278232 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.69e-12 | 6 | 120 | 5 | 16001084 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.69e-12 | 6 | 120 | 5 | 1869307 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 11390979 | ||
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 27632217 | ||
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 15081113 | ||
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 22699423 | ||
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 9.39e-12 | 7 | 120 | 5 | 16946704 | |
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 10857750 | ||
| Pubmed | 9.39e-12 | 7 | 120 | 5 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 9.39e-12 | 7 | 120 | 5 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 9.39e-12 | 7 | 120 | 5 | 26826184 | |
| Pubmed | SP1 KRT5 RIPOR2 HIPK1 APC NUP42 ARHGEF11 CEP350 ZNF106 USF3 ITSN2 TNRC6A NAV3 NAV2 NAV1 RAPGEF2 | 1.36e-11 | 486 | 120 | 16 | 20936779 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 2.50e-11 | 8 | 120 | 5 | 23204224 | |
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 29883445 | ||
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 10823932 | ||
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 2.50e-11 | 8 | 120 | 5 | 32339196 | |
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 33749946 | ||
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 22621333 | ||
| Pubmed | 2.50e-11 | 8 | 120 | 5 | 32686646 | ||
| Pubmed | 5.54e-11 | 20 | 120 | 6 | 25416063 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 5.60e-11 | 9 | 120 | 5 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 5.60e-11 | 9 | 120 | 5 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 5.60e-11 | 9 | 120 | 5 | 19695304 | |
| Pubmed | 5.60e-11 | 9 | 120 | 5 | 28235998 | ||
| Pubmed | 1.06e-10 | 22 | 120 | 6 | 26589352 | ||
| Pubmed | Dazl is a target RNA suppressed by mammalian NANOS2 in sexually differentiating male germ cells. | 1.06e-10 | 22 | 120 | 6 | 27072294 | |
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.12e-10 | 10 | 120 | 5 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.12e-10 | 10 | 120 | 5 | 38433229 | |
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 23810942 | ||
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 12837688 | ||
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 10601091 | ||
| Pubmed | 1.12e-10 | 10 | 120 | 5 | 9922113 | ||
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 7670487 | ||
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 11694340 | ||
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 9321470 | ||
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.35e-10 | 4 | 120 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.35e-10 | 4 | 120 | 4 | 11688365 | |
| Pubmed | 1.35e-10 | 4 | 120 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.35e-10 | 4 | 120 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.35e-10 | 4 | 120 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.35e-10 | 4 | 120 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.35e-10 | 4 | 120 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.35e-10 | 4 | 120 | 4 | 10936047 | |
| Interaction | CNOT9 interactions | PLEKHA4 APC PUM2 R3HDM2 DAZL ZNF318 BIRC6 CEP350 UBAP2L TNRC6A TMEM131 | 9.67e-08 | 231 | 116 | 11 | int:CNOT9 |
| Interaction | PUM2 interactions | 1.50e-07 | 144 | 116 | 9 | int:PUM2 | |
| Interaction | YWHAH interactions | DIP2B DENND4A TTC28 RALGAPB PLEKHA4 APC R3HDM2 FRYL RFX7 CCDC39 SHKBP1 CEP350 NHSL1 ZNF106 WWC2 EIF4B OSBPL6 NAV2 NAV1 MAST1 PLEKHA1 RAPGEF2 | 2.79e-07 | 1102 | 116 | 22 | int:YWHAH |
| Interaction | YWHAB interactions | DENND4A TTC28 RALGAPB PLEKHA4 APC R3HDM2 FRYL RFX7 SHKBP1 CEP350 NHSL1 ZNF106 WWC2 EIF4B ZRANB2 OSBPL6 NAV2 NAV1 MAST1 PLEKHA1 RAPGEF2 | 2.98e-07 | 1014 | 116 | 21 | int:YWHAB |
| Interaction | GSK3A interactions | DENND4A TTC28 TTC16 KIAA0586 PLEKHA4 APC ZDBF2 RFX7 ARHGEF11 CEP350 NHSL1 TNRC6A TOPORS PPP6R3 | 4.60e-07 | 464 | 116 | 14 | int:GSK3A |
| Interaction | YWHAG interactions | DENND4A RIPOR2 TTC28 RALGAPB PLEKHA4 APC R3HDM2 FRYL RFX7 SHKBP1 CEP350 NHSL1 ZNF106 WWC2 DLC1 EIF4B OSBPL6 NAV2 NAV1 PLEKHA1 KDR RAPGEF2 PPP6R3 | 5.85e-07 | 1248 | 116 | 23 | int:YWHAG |
| Interaction | YWHAE interactions | MAGEB4 DENND4A TTC28 RALGAPB PLEKHA4 APC R3HDM2 FRYL ZC3H18 DDB1 ZNF106 WWC2 EIF4B AMOTL1 ZRANB2 OSBPL6 NAV2 NAV1 MAST1 PLEKHA1 DEPDC5 RAPGEF2 WDR48 | 6.53e-07 | 1256 | 116 | 23 | int:YWHAE |
| Interaction | DAZ4 interactions | 6.40e-06 | 7 | 116 | 3 | int:DAZ4 | |
| Interaction | LATS1 interactions | KRT5 DVL1 PLEKHA4 APC DDB1 CEP350 WWC2 EIF4B AMOTL1 TNRC6A PLEKHA1 PPP6R3 | 8.95e-06 | 440 | 116 | 12 | int:LATS1 |
| Interaction | DAZL interactions | 2.09e-05 | 145 | 116 | 7 | int:DAZL | |
| Interaction | PHF21A interactions | 2.96e-05 | 343 | 116 | 10 | int:PHF21A | |
| Interaction | DAZ1 interactions | 2.96e-05 | 11 | 116 | 3 | int:DAZ1 | |
| Interaction | CPEB4 interactions | 3.35e-05 | 156 | 116 | 7 | int:CPEB4 | |
| Interaction | ATG16L1 interactions | DIP2B SP1 DENND4A TTC28 CDKN2AIP KIAA0586 DVL1 APC ANKRD50 DDB1 ITPR3 CEP350 PIKFYVE EIF4B ITSN2 ZRANB2 TNRC6A NAV1 WDR48 | 3.40e-05 | 1161 | 116 | 19 | int:ATG16L1 |
| Interaction | MAPRE3 interactions | 5.62e-05 | 230 | 116 | 8 | int:MAPRE3 | |
| Interaction | YWHAZ interactions | DENND4A RIPOR2 TTC28 RALGAPB PLEKHA4 APC R3HDM2 FRYL ZC3H18 NHSL1 WWC2 EIF4B AMOTL1 OSBPL6 NAV2 NAV1 MAST1 PLEKHA1 DEPDC5 RAPGEF2 | 6.04e-05 | 1319 | 116 | 20 | int:YWHAZ |
| Interaction | GOLGA1 interactions | 9.20e-05 | 183 | 116 | 7 | int:GOLGA1 | |
| Interaction | SMG5 interactions | 1.24e-04 | 84 | 116 | 5 | int:SMG5 | |
| Interaction | FBXO42 interactions | 1.28e-04 | 259 | 116 | 8 | int:FBXO42 | |
| Interaction | WDR70 interactions | 1.47e-04 | 87 | 116 | 5 | int:WDR70 | |
| Cytoband | Yq11.223 | 1.08e-04 | 93 | 120 | 4 | Yq11.223 | |
| GeneFamily | CD molecules|Mucins | 3.71e-10 | 21 | 82 | 6 | 648 | |
| GeneFamily | RNA binding motif containing | 4.14e-04 | 213 | 82 | 6 | 725 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.27e-04 | 161 | 82 | 5 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.45e-03 | 206 | 82 | 5 | 682 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 2.97e-03 | 18 | 82 | 2 | 620 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 2.97e-03 | 18 | 82 | 2 | 1269 | |
| GeneFamily | PDZ domain containing | 5.05e-03 | 152 | 82 | 4 | 1220 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.20e-09 | 12 | 116 | 5 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.20e-09 | 12 | 116 | 5 | MM781 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.90e-09 | 180 | 116 | 10 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAMLD1 PUM2 E2F3 R3HDM2 FRYL CEP350 PIKFYVE EVI5 BPTF DLC1 ITSN2 TMEM131 RAPGEF2 MED13 | 2.01e-08 | 466 | 116 | 14 | M13522 |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 4.91e-08 | 23 | 116 | 5 | MM1293 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | TENT4A PUM2 E2F3 FRYL ZNF318 CEP350 PIKFYVE BPTF NAV3 AUTS2 RAPGEF2 | 9.96e-08 | 300 | 116 | 11 | M8702 |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 1.92e-07 | 93 | 116 | 7 | MM1185 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TTC28 MAMLD1 APC PUM2 E2F3 R3HDM2 FRYL CEP350 PIKFYVE EVI5 BPTF DLC1 ITSN2 NAV3 TMEM131 RAPGEF2 MED13 | 2.31e-07 | 856 | 116 | 17 | M4500 |
| Coexpression | MATZUK_SPERMATOGONIA | 2.41e-07 | 31 | 116 | 5 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 3.35e-07 | 33 | 116 | 5 | MM701 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.49e-06 | 181 | 116 | 8 | M8187 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 3.14e-06 | 200 | 116 | 8 | M7839 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CAMK1D AFF3 FRYL RFX7 SHKBP1 PIKFYVE UBAP2L EIF4B TNRC6A AUTS2 NAV1 | 7.48e-06 | 467 | 116 | 11 | M1347 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DIP2B RIPOR2 KIF1A AFF3 APC POU2F2 ZNF318 RFX7 FRY CNTN5 TNRC6A OSBPL6 NAV3 AUTS2 NAV1 MAST1 PLEKHA1 | 7.50e-06 | 1106 | 116 | 17 | M39071 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CAMK1D AFF3 FRYL RFX7 SHKBP1 PIKFYVE UBAP2L EIF4B TNRC6A AUTS2 NAV1 | 1.05e-05 | 484 | 116 | 11 | MM999 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | KRT5 SPRY2 RIPOR2 KIF1A GLIS3 APC NDRG2 CCDC39 EVI5 EGR2 OSBPL6 SHISA3 | 1.47e-05 | 600 | 116 | 12 | M39055 |
| Coexpression | MADAN_DPPA4_TARGETS | 4.07e-05 | 86 | 116 | 5 | MM1312 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 6.74e-05 | 155 | 116 | 6 | M39246 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | BNC2 KRT5 CAMK1D DVL1 PLEKHA4 IRF7 ITPR3 NHSL1 WWC2 FRY NAV2 PLEKHA1 | 6.91e-05 | 704 | 116 | 12 | M45672 |
| Coexpression | PILON_KLF1_TARGETS_UP | 8.22e-05 | 503 | 116 | 10 | M2226 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | SP1 BNC2 KRT5 CAMK1D PLEKHA4 IRF7 ANKRD50 ITPR3 NHSL1 WWC2 FRY ITSN2 NAV2 PLEKHA1 | 8.49e-05 | 955 | 116 | 14 | M45680 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DENND4A RIPOR2 HIPK1 RALGAPB PUM2 POU2F2 FRYL RFX7 BIRC6 CEP350 PCNX2 PIKFYVE BPTF EIF4B ITSN2 AUTS2 TNFRSF1B MED13 | 9.74e-05 | 1492 | 116 | 18 | M40023 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 9.84e-05 | 166 | 116 | 6 | M6826 | |
| Coexpression | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 | 1.37e-04 | 59 | 116 | 4 | M1238 | |
| Coexpression | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 | 1.37e-04 | 59 | 116 | 4 | MM528 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.49e-04 | 541 | 116 | 10 | MM1061 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.50e-04 | 439 | 116 | 9 | M39054 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 1.68e-04 | 183 | 116 | 6 | M8189 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 2.05e-04 | 190 | 116 | 6 | M4662 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS | 2.30e-04 | 194 | 116 | 6 | M40292 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 2.30e-04 | 194 | 116 | 6 | M7313 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP | 2.36e-04 | 195 | 116 | 6 | M8421 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP | 2.43e-04 | 196 | 116 | 6 | M9578 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 2.50e-04 | 197 | 116 | 6 | M8464 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN | 2.50e-04 | 197 | 116 | 6 | M8755 | |
| Coexpression | GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP | 2.64e-04 | 199 | 116 | 6 | M3493 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.64e-04 | 199 | 116 | 6 | M7259 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 2.64e-04 | 199 | 116 | 6 | M3177 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.64e-04 | 199 | 116 | 6 | M6987 | |
| Coexpression | GSE27786_BCELL_VS_NKTCELL_UP | 2.71e-04 | 200 | 116 | 6 | M4808 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN | 2.71e-04 | 200 | 116 | 6 | M4015 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP | 2.71e-04 | 200 | 116 | 6 | M4021 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN | 2.71e-04 | 200 | 116 | 6 | M8647 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 2.71e-04 | 200 | 116 | 6 | M5679 | |
| Coexpression | BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP | 2.90e-04 | 286 | 116 | 7 | M34008 | |
| Coexpression | LIU_SOX4_TARGETS_UP | 3.91e-04 | 139 | 116 | 5 | M17450 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 3.94e-04 | 301 | 116 | 7 | M45708 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RIPOR2 SGIP1 PUM2 FRYL WWC2 FRY AMOTL1 ITSN2 ADGRF5 RAPGEF2 MED13 SHISA3 | 4.10e-04 | 854 | 116 | 12 | M1533 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 4.17e-04 | 141 | 116 | 5 | M7720 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.20e-04 | 505 | 116 | 9 | M39167 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | PIK3AP1 ABCA1 DENND4A RIPOR2 AFF3 POU2F2 ZNF318 ITPR3 PIKFYVE FRY ITSN2 MED13 | 5.67e-07 | 361 | 114 | 12 | GSM538219_500 |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | PIK3AP1 ABCA1 DENND4A RIPOR2 AFF3 POU2F2 ZNF318 ITPR3 PIKFYVE ITSN2 MED13 | 2.17e-06 | 339 | 114 | 11 | GSM403988_500 |
| CoexpressionAtlas | B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3 | PIK3AP1 ABCA1 DENND4A RIPOR2 AFF3 POU2F2 ZNF318 PIKFYVE FRY ITSN2 MED13 | 2.57e-06 | 345 | 114 | 11 | GSM538201_500 |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | PIK3AP1 ABCA1 DENND4A RIPOR2 AFF3 POU2F2 ZNF318 ITPR3 PIKFYVE FRY MED13 | 4.65e-06 | 367 | 114 | 11 | GSM399440_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | DIP2B CCDC60 ABCA1 DENND4A DAZL NHSL1 DLC1 PXDN EGR2 AMOTL1 ITSN2 NAV3 NAV1 PLEKHA1 KDR ADGRF5 | 9.37e-06 | 831 | 114 | 16 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | ABCA1 DENND4A DAZL FRYL NHSL1 DLC1 PXDN EGR2 AMOTL1 ITSN2 NAV3 NAV1 PLEKHA1 KDR ADGRF5 RAPGEF2 | 1.19e-05 | 847 | 114 | 16 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | ABCA1 DENND4A RIPOR2 AFF3 POU2F2 ZNF318 PIKFYVE FRY ITSN2 MED13 | 2.04e-05 | 352 | 114 | 10 | GSM538198_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP1 BNC2 RIPOR2 KIAA0586 DAZL ZNF318 BIRC6 WWC2 UBAP2L TNRC6A NAV2 KDR DEPDC5 TOPORS SHISA3 | 2.71e-05 | 806 | 114 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 5.57e-05 | 76 | 114 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | BNC2 ABCA1 RIPOR2 AFF3 MUC16 ZDBF2 ANKRD50 NDRG2 CEP350 DLC1 PXDN EGR2 NAV1 CLMP | 6.87e-05 | 773 | 114 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.44e-05 | 336 | 114 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.06e-05 | 44 | 114 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_1000 | |
| CoexpressionAtlas | B cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 1.10e-04 | 348 | 114 | 9 | GSM538216_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | DIP2B ABCA1 DENND4A TTC28 DAZL NHSL1 DLC1 PXDN ITSN2 NAV3 NAV1 PLEKHA1 KDR ADGRF5 | 1.23e-04 | 817 | 114 | 14 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.31e-04 | 356 | 114 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.37e-04 | 209 | 114 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 1.49e-04 | 148 | 114 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.62e-04 | 51 | 114 | 4 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.34e-04 | 385 | 114 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 2.35e-04 | 161 | 114 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.68e-04 | 165 | 114 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.72e-04 | 310 | 114 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SP1 BNC2 RIPOR2 AFF3 NDRG2 BIRC6 TNRC6A NAV2 NAV1 KDR DEPDC5 CLMP TOPORS | 3.23e-04 | 790 | 114 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 3.58e-04 | 408 | 114 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SP1 BNC2 RIPOR2 AFF3 NDRG2 BIRC6 AMOTL1 TNRC6A NAV2 NAV1 KDR DEPDC5 TOPORS | 3.59e-04 | 799 | 114 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SP1 BNC2 AFF3 DAZL BIRC6 AMOTL1 TNRC6A NAV2 NAV1 KDR DEPDC5 CLMP TOPORS | 3.68e-04 | 801 | 114 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 4.06e-04 | 415 | 114 | 9 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.13e-04 | 330 | 114 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | CCDC60 ABCA1 DENND4A NHSL1 DLC1 EGR2 AMOTL1 ITSN2 NAV3 NAV1 PLEKHA1 KDR ADGRF5 | 4.44e-04 | 817 | 114 | 13 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 4.48e-04 | 28 | 114 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.20e-04 | 523 | 114 | 10 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 5.51e-04 | 30 | 114 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.74e-04 | 125 | 114 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | PIK3AP1 ABCA1 DENND4A DAZL ANKRD50 DLC1 PXDN ITSN2 NAV3 NAV1 PLEKHA1 KDR ADGRF5 | 6.15e-04 | 846 | 114 | 13 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | B cells, B.T1.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23-, Spleen, avg-3 | 6.43e-04 | 353 | 114 | 8 | GSM538213_500 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.26e-09 | 193 | 117 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-09 | 199 | 117 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.27e-08 | 185 | 117 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.91e-08 | 195 | 117 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.31e-08 | 197 | 117 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.66e-07 | 164 | 117 | 7 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 5.00e-07 | 180 | 117 | 7 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-07 | 191 | 117 | 7 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-07 | 191 | 117 | 7 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-07 | 193 | 117 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.98e-07 | 193 | 117 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-07 | 193 | 117 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-07 | 194 | 117 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.55e-07 | 195 | 117 | 7 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.55e-07 | 195 | 117 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.16e-07 | 197 | 117 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.47e-07 | 198 | 117 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 9.80e-07 | 199 | 117 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-06 | 200 | 117 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.73e-06 | 174 | 117 | 6 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.95e-06 | 175 | 117 | 6 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 7.42e-06 | 177 | 117 | 6 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 7.66e-06 | 178 | 117 | 6 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 7.91e-06 | 179 | 117 | 6 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-06 | 182 | 117 | 6 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.70e-06 | 182 | 117 | 6 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-06 | 182 | 117 | 6 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.55e-06 | 185 | 117 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-06 | 185 | 117 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.01e-05 | 187 | 117 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 187 | 117 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-05 | 188 | 117 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 188 | 117 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 189 | 117 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.08e-05 | 189 | 117 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 189 | 117 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.08e-05 | 189 | 117 | 6 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-05 | 190 | 117 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.18e-05 | 192 | 117 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 192 | 117 | 6 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.18e-05 | 192 | 117 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 192 | 117 | 6 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 192 | 117 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 193 | 117 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 193 | 117 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 193 | 117 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 193 | 117 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.21e-05 | 193 | 117 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.21e-05 | 193 | 117 | 6 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 194 | 117 | 6 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 194 | 117 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | f55ab1018a6cde7d517b53e6ce44c3f7bde485c4 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | ea1b00805391dca8be0883b635768b296369919a | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.29e-05 | 195 | 117 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 126f46dd15dddcf5701144718bb8ba1ce84b2d1d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 85df110f753f58ab017018c54ee454edb4428e29 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.29e-05 | 195 | 117 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 195 | 117 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 196 | 117 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-05 | 196 | 117 | 6 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-05 | 196 | 117 | 6 | c57a95f8b4d8d6334f269d3c16246684f4222a3e | |
| ToppCell | Severe-NK|Severe / Disease group and Cell class | 1.33e-05 | 196 | 117 | 6 | 66130d38b67e51e2385de8a89227759fd137999c | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-05 | 196 | 117 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 197 | 117 | 6 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 1.36e-05 | 197 | 117 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 197 | 117 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 197 | 117 | 6 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 197 | 117 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-05 | 198 | 117 | 6 | 88bb764b21ca50e56f6c536a2d61d35afd8c3f36 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 198 | 117 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 198 | 117 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 198 | 117 | 6 | 9895f1d65d18d939f3974a914ee41c6d5575e765 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 198 | 117 | 6 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.44e-05 | 199 | 117 | 6 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | fd6b4ff4330db11c03f1eb4e06b43a162326f744 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | 8795920911ee75c09a97cc948c14ad7301b27796 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.48e-05 | 148 | 117 | 5 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.48e-05 | 148 | 117 | 5 | f90ee6fbd71b5e0512af34867202f38409f4de38 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.49e-05 | 160 | 117 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 165 | 117 | 5 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 165 | 117 | 5 | d2c79653710b139794170f3d72f11392fc548ac7 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.73e-05 | 166 | 117 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.18e-05 | 168 | 117 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.41e-05 | 169 | 117 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 170 | 117 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 8.65e-05 | 170 | 117 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 8.65e-05 | 170 | 117 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 8.89e-05 | 171 | 117 | 5 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| Drug | AZFd | 1.69e-09 | 23 | 119 | 6 | CID000196489 | |
| Drug | boron trichloride | 1.06e-08 | 6 | 119 | 4 | CID000025135 | |
| Drug | Vistar | 1.19e-06 | 36 | 119 | 5 | CID000040896 | |
| Drug | desmethylazelastine | 1.23e-06 | 16 | 119 | 4 | CID000162558 | |
| Drug | kt S | 1.26e-06 | 66 | 119 | 6 | CID006399216 | |
| Drug | dazmegrel | 2.59e-06 | 19 | 119 | 4 | CID000053555 | |
| Drug | YM 026 | 2.59e-06 | 19 | 119 | 4 | CID000004443 | |
| Drug | dansylaziridine | 5.82e-06 | 23 | 119 | 4 | CID000104008 | |
| Drug | azafagomine | 1.21e-05 | 57 | 119 | 5 | CID011957435 | |
| Drug | d-gluconhydroximo-1,5-lactam | 2.00e-05 | 31 | 119 | 4 | CID000003479 | |
| Drug | 3-bromo-7-nitroindazole | 3.67e-05 | 36 | 119 | 4 | CID000001649 | |
| Drug | p11-13 | 4.62e-05 | 75 | 119 | 5 | CID000015759 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.62e-08 | 8 | 117 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.62e-08 | 8 | 117 | 4 | C1507149 | |
| Disease | non-high density lipoprotein cholesterol measurement | DIP2B SP1 BNC2 ABCA1 GLIS3 POU2F2 E2F3 R3HDM2 EVI5 BPTF DLC1 ITSN2 UGT2B15 | 5.31e-06 | 713 | 117 | 13 | EFO_0005689 |
| Disease | cortical thickness | DIP2B SP1 BNC2 RIPOR2 GLIS3 ZNF318 PLEKHM1 NHSL1 ZNF106 DLC1 TNRC6A NAV3 NAV2 AUTS2 NAV1 TMEM131 | 8.50e-06 | 1113 | 117 | 16 | EFO_0004840 |
| Disease | FEV/FEC ratio | BNC2 SPRY2 CAMK1D KIAA0586 AFF3 GLIS3 R3HDM2 FANCE ZNF106 WWC2 DLC1 CNTN5 NAV2 NAV1 KDR MIGA1 | 2.83e-05 | 1228 | 117 | 16 | EFO_0004713 |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.28e-05 | 16 | 117 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.28e-05 | 16 | 117 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.28e-05 | 16 | 117 | 3 | 415000 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.97e-05 | 17 | 117 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | keratoconjunctivitis (is_marker_for) | 4.66e-05 | 3 | 117 | 2 | DOID:9368 (is_marker_for) | |
| Disease | neuroimaging measurement | DIP2B SP1 AFF3 GLIS3 APC RNF34 FRYL ARHGEF11 NHSL1 ZNF106 TNRC6A NAV3 NAV2 RAPGEF2 | 8.83e-05 | 1069 | 117 | 14 | EFO_0004346 |
| Disease | Headache, HOMA-IR | 9.30e-05 | 4 | 117 | 2 | EFO_0004501, HP_0002315 | |
| Disease | platelet-to-lymphocyte ratio | 1.03e-04 | 363 | 117 | 8 | EFO_0008446 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 1.55e-04 | 5 | 117 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | cortical surface area measurement | SP1 BNC2 SPRY2 GLIS3 APC FRYL PLEKHM1 EVI5 NHSL1 ZNF106 TNRC6A NAV3 NAV2 AUTS2 NAV1 | 2.83e-04 | 1345 | 117 | 15 | EFO_0010736 |
| Disease | ovarian carcinoma | 3.02e-04 | 321 | 117 | 7 | EFO_0001075 | |
| Disease | Headache, HOMA-B | 3.23e-04 | 7 | 117 | 2 | EFO_0004469, HP_0002315 | |
| Disease | COVID-19 symptoms measurement | 3.62e-04 | 35 | 117 | 3 | EFO_0600019 | |
| Disease | chronic obstructive pulmonary disease | 4.23e-04 | 688 | 117 | 10 | EFO_0000341 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 4.30e-04 | 8 | 117 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 4.30e-04 | 8 | 117 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 4.30e-04 | 8 | 117 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 4.30e-04 | 8 | 117 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 4.30e-04 | 8 | 117 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 4.30e-04 | 8 | 117 | 2 | C0393703 | |
| Disease | neuroticism measurement, cognitive function measurement | 4.35e-04 | 566 | 117 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Myoclonic Epilepsy | 5.51e-04 | 9 | 117 | 2 | C0014550 | |
| Disease | cognitive function measurement | DENND4A TTC28 AFF3 ZDBF2 BIRC6 PLEKHM1 CNTN5 ITSN2 TNRC6A AUTS2 UGT2B15 MAST1 PLEKHA1 TMEM131 CLMP | 5.54e-04 | 1434 | 117 | 15 | EFO_0008354 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 6.12e-04 | 97 | 117 | 4 | DOID:3083 (is_marker_for) | |
| Disease | Epilepsy, Myoclonic, Infantile | 6.87e-04 | 10 | 117 | 2 | C0917800 | |
| Disease | dry eye syndrome (is_marker_for) | 6.87e-04 | 10 | 117 | 2 | DOID:10140 (is_marker_for) | |
| Disease | ovarian serous carcinoma | 8.14e-04 | 46 | 117 | 3 | EFO_1001516 | |
| Disease | pulmonary fibrosis | 8.38e-04 | 11 | 117 | 2 | EFO_0009448 | |
| Disease | Myoclonic Astatic Epilepsy | 8.38e-04 | 11 | 117 | 2 | C0393702 | |
| Disease | reticulocyte measurement | SP1 BNC2 ABCA1 DENND4A AFF3 PLEKHA4 BIRC6 PIKFYVE CNTN5 MAST1 TMEM131 DEPDC5 | 9.86e-04 | 1053 | 117 | 12 | EFO_0010700 |
| Disease | body surface area | 1.07e-03 | 643 | 117 | 9 | EFO_0022196 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 1.17e-03 | 52 | 117 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | X-11444 measurement | 1.18e-03 | 13 | 117 | 2 | EFO_0021237 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.18e-03 | 13 | 117 | 2 | C0751122 | |
| Disease | HOMA-B | 1.37e-03 | 55 | 117 | 3 | EFO_0004469 | |
| Disease | idiopathic pulmonary fibrosis | 1.52e-03 | 57 | 117 | 3 | EFO_0000768 | |
| Disease | brain measurement, neuroimaging measurement | 1.60e-03 | 550 | 117 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Malignant Neoplasms | 1.72e-03 | 128 | 117 | 4 | C0006826 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.76e-03 | 60 | 117 | 3 | C4722327 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.12e-03 | 64 | 117 | 3 | DOID:4947 (is_marker_for) | |
| Disease | rheumatoid arthritis, COVID-19 | 2.12e-03 | 64 | 117 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | interstitial lung disease | 2.42e-03 | 67 | 117 | 3 | EFO_0004244 | |
| Disease | synophrys measurement | 2.52e-03 | 68 | 117 | 3 | EFO_0007906 | |
| Disease | Prostate cancer, familial | 2.63e-03 | 69 | 117 | 3 | C2931456 | |
| Disease | obsolete_red blood cell distribution width | DIP2B SP1 TTC28 TENT4A R3HDM2 BIRC6 MUC17 CNTN5 UGT2B15 MAST1 MIGA1 CLMP PPP6R3 | 2.67e-03 | 1347 | 117 | 13 | EFO_0005192 |
| Disease | red blood cell density measurement | SP1 DENND4A AFF3 R3HDM2 RFX7 ARHGEF11 ZNF106 WWC2 TPRXL ADGRF5 | 2.67e-03 | 880 | 117 | 10 | EFO_0007978 |
| Disease | chin morphology measurement | 2.74e-03 | 70 | 117 | 3 | EFO_0007842 | |
| Disease | exercise test | 2.83e-03 | 20 | 117 | 2 | EFO_0004328 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.97e-03 | 355 | 117 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | reticulocyte count | SP1 BNC2 ABCA1 DENND4A PLEKHA4 BIRC6 PIKFYVE CNTN5 MAST1 TMEM131 DEPDC5 | 2.97e-03 | 1045 | 117 | 11 | EFO_0007986 |
| Disease | upper aerodigestive tract neoplasm | 3.04e-03 | 246 | 117 | 5 | EFO_0004284 | |
| Disease | visceral adipose tissue measurement | 3.12e-03 | 481 | 117 | 7 | EFO_0004765 | |
| Disease | aspartate aminotransferase measurement | PIK3AP1 ABCA1 TTC28 CDKN2AIP R3HDM2 ZC3H18 BIRC6 PLEKHM1 WWC2 OSBPL6 | 3.24e-03 | 904 | 117 | 10 | EFO_0004736 |
| Disease | breast cancer, COVID-19 | 3.42e-03 | 22 | 117 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | Hepatitis | 3.42e-03 | 22 | 117 | 2 | HP_0012115 | |
| Disease | waist-hip ratio | ABCA1 TTC28 AFF3 ZNF318 RFX7 BIRC6 BPTF DLC1 CNTN5 TNRC6A NAV3 ADGRF5 | 3.48e-03 | 1226 | 117 | 12 | EFO_0004343 |
| Disease | vital capacity | DIP2B BNC2 KIF1A AFF3 GLIS3 PLEKHM1 FANCE ZNF106 OSBPL6 AUTS2 KDR MIGA1 | 3.72e-03 | 1236 | 117 | 12 | EFO_0004312 |
| Disease | nicotine dependence | 3.72e-03 | 78 | 117 | 3 | EFO_0003768 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.73e-03 | 23 | 117 | 2 | C0018784 | |
| Disease | age of onset of asthma | 3.86e-03 | 79 | 117 | 3 | OBA_2001001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERSDTLSFSSLTSST | 171 | Q495M9 | |
| SSSRLATSTSNTLSA | 841 | P51826 | |
| TSARSASLSSAATTG | 3736 | Q9NR09 | |
| SATQTSASIVSSSLL | 6 | A6NCI8 | |
| SSSLLSAVDVSSSLT | 16 | A6NCI8 | |
| DLSTTSSLQSSSSIH | 961 | Q6ZN30 | |
| SSLQSSSSIHSSRES | 966 | Q6ZN30 | |
| ESSLSSCRNSSSTVS | 1136 | O95477 | |
| TRLHQSASSSTSSLS | 646 | O15085 | |
| SASSSTSSLSTRSLE | 651 | O15085 | |
| ETSSTTNRSSVTLSL | 121 | Q5T7R7 | |
| TSALSSIASTTAASS | 851 | Q8IY63 | |
| SSKNSSLRTTSSTAT | 1186 | Q9ULJ7 | |
| STASSTSNRSSTRSL | 721 | Q6ZUJ8 | |
| TSNRSSTRSLLSVSS | 726 | Q6ZUJ8 | |
| SLTSATSTSNIQSSA | 2246 | Q12830 | |
| STISREASTQSSSAA | 11 | Q13117 | |
| STISREASTQSSSAA | 11 | Q9NR90 | |
| QTTLKSSERSSSTSA | 341 | Q8IWA6 | |
| SLSARSSRSTSTSTS | 886 | Q9UFE4 | |
| SSRSTSTSTSQSSIK | 891 | Q9UFE4 | |
| TSAQSTLHSLSTSSS | 1071 | O94779 | |
| TLHSLSTSSSSVTLL | 1076 | O94779 | |
| LTTKATTTRATSSTS | 4366 | Q9HC84 | |
| TSSKDQSSDRTSLSS | 1346 | Q7Z401 | |
| SRTSSSRQSSTDSEL | 306 | Q9Y2K5 | |
| SAFLSAATTSTSSSL | 186 | P11161 | |
| QASSTNASLISTSST | 166 | Q99504 | |
| LIDLGSSSSTSSTAS | 211 | Q9NZM3 | |
| SSSLTNSSQSSSLFS | 526 | Q8TB72 | |
| SSASSSATRRESLST | 576 | Q8TB72 | |
| RTTLRQSATSATSSN | 266 | Q14573 | |
| LLVSVTGNSSSSSSS | 211 | Q8N109 | |
| SSSQQLVASSLTSSS | 1161 | O75140 | |
| ISQATLTLDTSSTAS | 5871 | Q8WXI7 | |
| FSSLSSLSVSSSVST | 316 | A8MTJ6 | |
| SSSSVLRDTASSSLA | 41 | O15481 | |
| NASSSQASTSTERSL | 91 | O15481 | |
| TNSESSTVSSRASTA | 181 | Q5SSG8 | |
| STVSSRASTATNSES | 186 | Q5SSG8 | |
| SSSTAAAATLSLANS | 591 | Q86Z02 | |
| SSSSVKFVSTTSSSR | 571 | P13647 | |
| SSTNTSLLTSKSTSQ | 351 | Q9NXV6 | |
| LLVSVTGNSSSSSSS | 211 | Q8NHK3 | |
| LISSVSISSSSTSLS | 896 | Q5SYE7 | |
| LIRSSLGSSTSSTLS | 2016 | A6NKB5 | |
| RSSTSSIDSNVSSKS | 1156 | Q8IVL0 | |
| SSTSSSSSRQSLGLS | 1871 | Q8IVL0 | |
| SLVSSSSASSNLSHL | 116 | O60447 | |
| TQNKSSSLSTSSILS | 601 | Q32MH5 | |
| LSSSSTSSSISLGNN | 1711 | O94915 | |
| SSSLSLNSLSSSRSS | 396 | Q8WXX7 | |
| TSSSSSSSSIRPANI | 226 | Q9P265 | |
| LCFSLSRLSSSVSSS | 256 | Q8TDS7 | |
| QASSSLSTTVTTLSS | 391 | P09086 | |
| RTSSTTSATTTSRIS | 2376 | P98088 | |
| SSLDSSSLSLCLSSA | 471 | Q92985 | |
| SASSSTSSQRDSRQS | 21 | Q9BZF3 | |
| HTSRSLSSLNRSLSS | 1106 | Q9Y2H9 | |
| QLLSSGSSASSVSSL | 581 | Q5XG87 | |
| NSSISTSLSASSSII | 366 | O15504 | |
| FLTTLSSQSSTSSTH | 1561 | Q9Y2I7 | |
| STISREASTQSSSAA | 11 | Q9NQZ3 | |
| STISREASTQSSSAA | 176 | Q9NQZ3 | |
| STISREASTQSSSAA | 341 | Q9NQZ3 | |
| LTTNTSTTSCSSSLQ | 61 | O00716 | |
| SLASTTLSLTESQSA | 51 | Q8NEA6 | |
| DSSPSSTSTSNSQRL | 256 | Q5VT06 | |
| ASSATASSTATATLQ | 581 | Q13495 | |
| SRLSSSTEQSTSSRL | 201 | O14640 | |
| STISREASTQSSSAA | 11 | Q92904 | |
| STISREASTQSSSAA | 11 | Q86SG3 | |
| STISREASTQSSSAA | 176 | Q86SG3 | |
| TSSASRLLTTALTSF | 376 | Q9HB96 | |
| DSGLSSSSTSSSISL | 1751 | Q5TBA9 | |
| SRLSSSTEQSTSSRL | 201 | P54792 | |
| ASTQALSSSVSSSKL | 756 | Q16531 | |
| LSSSVSSSKLFSSST | 761 | Q16531 | |
| SLSALSSRAASVSSL | 406 | Q12756 | |
| DSSASTSQSTRAASI | 346 | P23588 | |
| TTLLANSEASTLSTT | 2701 | Q685J3 | |
| TATNTLSSLTSSILS | 281 | Q9H195 | |
| SSCSSSRQNLTLSLS | 126 | Q8NAN2 | |
| SSDSISSLNSITSHS | 1181 | Q8NEY1 | |
| KLTASSLSLDTASSS | 246 | Q9Y4G2 | |
| LSSSSSVSSLNSSTL | 236 | Q8IYJ3 | |
| SRTLSQSSESGTLSS | 346 | Q9UN36 | |
| SLASSASTISSLSSL | 11 | Q9H4M7 | |
| RSSTSSIDSNISSKS | 1231 | Q8IVL1 | |
| LLSSVAESSSNTSSR | 711 | Q7Z3Z4 | |
| RISLTSLHSASSNTS | 626 | Q8TBC3 | |
| RAPSRQSSTATSSSS | 156 | A0PJX4 | |
| SSLTSIFNSSSTLFT | 396 | Q2M3M2 | |
| VATANSTLTTASTSS | 1526 | Q9UHV7 | |
| SSASLVSSQASSSSF | 306 | P08047 | |
| KRSVSNSTQTSSSSS | 731 | Q96QB1 | |
| SSLDSSNASVSSSLS | 326 | Q8IU85 | |
| SRSRSSSLSLTVESA | 646 | Q9Y4F9 | |
| STRTSTSSSSSEQRL | 121 | O43597 | |
| TSSSSSEQRLLGSSF | 126 | O43597 | |
| TSSSLENSSSASSLL | 1331 | Q8IZF2 | |
| RTGSSSSILSASSES | 2566 | P25054 | |
| SSSSLSSESSRLSTE | 96 | Q99941 | |
| SSSTRSTANSASRSQ | 301 | Q9H6B4 | |
| STANSASRSQRTLST | 306 | Q9H6B4 | |
| FLNSLSSDDTSSLSS | 731 | G9CGD6 | |
| SEISSRSSIVSNSSF | 1146 | Q9Y4G8 | |
| VLSSSAASSTITALS | 421 | P32780 | |
| KSVASLSSRSSLSSL | 541 | Q6AWC2 | |
| ALTASNNTVTTSSLS | 151 | Q8TAF3 | |
| QNTLSSSTSSGRTST | 701 | Q14157 | |
| TSSLNSSRSQTSSFF | 161 | Q969K3 | |
| ARAESTSSISSTNSL | 501 | Q9BQI5 | |
| TSSISSTNSLSAATT | 506 | Q9BQI5 | |
| TTRNSTSCTSSTSSL | 211 | Q6ZQN7 | |
| TSSSSSQSSSILGSL | 1196 | Q96PX9 | |
| SSTSSRTSAQAASSQ | 1241 | Q92545 | |
| ASLSASAASTSTSTQ | 121 | O15391 | |
| LSNSTSAFSTRSDAS | 1366 | Q92626 | |
| NKSVQSSRSSLSSDS | 696 | Q9HCK1 | |
| SSLSASNSTQTFSVT | 641 | Q68DE3 | |
| RSSSSSSRSILSSSI | 36 | Q17RH7 | |
| SSRSILSSSILSSSI | 41 | Q17RH7 | |
| TLSVASQNLTFTSSS | 526 | Q2KHR2 | |
| ETTANSSTSLRSTTL | 1371 | Q86X10 | |
| SRSSSSSQSRSRSSS | 231 | O95218 | |
| SSSSLESLASAQSVS | 1951 | Q96AY4 | |
| RSQTLSLSSESTSRS | 656 | Q9NS56 | |
| LSLVSSSSRGNTSTL | 271 | Q8TEC5 | |
| RSTSATAVTFSDSSL | 636 | Q8NEE8 | |
| SSSSSLESSASALDR | 326 | P20333 | |
| RRLDSITSSQSSASS | 961 | P35968 | |
| LTSSASTLVNASKSS | 56 | P54855 | |
| ATSHSTASRSNSLVS | 321 | Q9HB21 | |
| FTSSLSTKDSLRSNS | 726 | Q5H9R7 | |
| NSNLSRTKSSDTSST | 1601 | Q5VUA4 | |
| SSSASSALAISSLAD | 981 | Q9H2Y7 | |
| SSTAQSTSARNSDSK | 1686 | Q8NDV7 | |
| SLTRKSESSNTTSLT | 376 | Q9BVV6 | |
| RSRSLSVSSVSSVSS | 701 | Q86VM9 |